tiprankstipranks
TipRanksTop Financial ExpertsInsidersFairmount Funds Management LLC

Fairmount Funds Management LLC Insider Profile

4 Followers
Fairmount Funds Management LLC, Director at Cogent Biosciences, holds 3.37M shares in Oruka Therapeutics (Ticker: ORKA), holds 2.70M shares in Dianthus Therapeutics (Ticker: DNTH), holds 3.45M shares in Viridian Therapeutics (Ticker: VRDN).
tipranks
Fairmount Funds Management LLC

Fairmount Funds Management LLC
Cogent Biosciences (COGT)
Director

Ranked #1,972 out of 99,797 Corporate Insiders

Profitable Transactions

67%
8 out of 12 Profitable Transactions

Average Return

+47.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$474M
23.58%
21.34%
14.77%
13.62%
26.69% Others
A breakdown of Fairmount Funds Management LLC's holdings

Insider Roles

Spyre Therapeutics
(SYRE)
Director
Apogee Therapeutics, Inc.
(APGE)
Director
Oruka Therapeutics
(ORKA)
Director, Ten Percent Owner
Viridian Therapeutics
(VRDN)
Director, Ten Percent Owner
+3 other positions
Roles that Fairmount Funds Management LLC holds in companies

Most Profitable Insider Trade

Stock:
Apogee Therapeutics, Inc.
(APGE)
Rating:Informative Buy
Date:Jul 17, 2023 - Jul 17, 2024
Return:+136.50%
The most profitable trade made by Fairmount Funds Management LLC

Fairmount Funds Management LLC's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Cogent Biosciences
Jun 12, 2024
Director
Uninformative Buy
12.90M
$48.56M
Viridian Therapeutics
Sep 17, 2024
Director, Ten Percent Owner
Informative Buy
30.00M
$64.54M
Apogee Therapeutics, Inc.
Apr 01, 2024
Director
Uninformative Sell
$101.14M
Dianthus Therapeutics
Oct 01, 2024
Director
Uninformative Sell
$62.22M
Spyre Therapeutics
Apr 25, 2024
Director
Uninformative Buy
118.18M
$111.72M
Oruka Therapeutics
Nov 21, 2024
Director, Ten Percent Owner
Uninformative Buy
3.57M
$70.00M
Zenas BioPharma, Inc.
Sep 16, 2024
Director
Uninformative Buy
$15.66M
List of latest transactions for each holding click on a transaction to see Fairmount Funds Management LLC's performance on stock

Fairmount Funds Management LLC insider profile FAQ

What is the percentage of profitable transactions made by Fairmount Funds Management LLC?
The percentage of profitable transactions made by Fairmount Funds Management LLC is 67%.
    What is the average return per transaction made by Fairmount Funds Management LLC?
    The average return per transaction made by Fairmount Funds Management LLC is 47.70%.
      What stocks does Fairmount Funds Management LLC hold?
      Fairmount Funds Management LLC holds: COGT, VRDN, APGE, DNTH, SYRE, ORKA, ZBIO stocks.
        What was Fairmount Funds Management LLC’s latest transaction?
        Fairmount Funds Management LLC latest transaction was an Uninformative Buy of $3.57M.
          What was Fairmount Funds Management LLC's most profitable transaction?
          Fairmount Funds Management LLC’s most profitable transaction was an Informative Buy of APGE stock on July 17, 2023. The return on the trade was 136.50%.
            What is Fairmount Funds Management LLC's role in Cogent Biosciences?
            Fairmount Funds Management LLC's role in Cogent Biosciences is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.